About This Study
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) is a nerve disease that causes weakness and numbness. The purpose of this study is to learn more about a new medicine called TAK-881 for this disease. Everyone in the study will get TAK-881, and doctors will compare it to another medicine called HYQVIA. The goal is to find out if TAK-881 works better or is easier to use.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 100+ years old
- All Genders
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- Reimbursement offered
Study Locations
- Greater Winston-Salem, NC